IBRUTINIB

80997 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking IBRUTINIB:

# Side effect Count
0 DEATH 8652
1 OFF LABEL USE 6069
2 FATIGUE 4780
3 DIARRHOEA 4224
4 ATRIAL FIBRILLATION 3926
5 PNEUMONIA 3291
6 CONTUSION 2827
7 INCORRECT DOSE ADMINISTERED 2779
8 FALL 2544
9 ASTHENIA 2378
See all common reactions for IBRUTINIB

IBRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMATOTYMPANUM 35 0.4118
1 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 38 0.4043
2 MANTLE CELL LYMPHOMA RECURRENT 169 0.3885
3 MICROGRAPHIC SKIN SURGERY 61 0.2837
4 MANTLE CELL LYMPHOMA 406 0.2666
5 ANGINA BULLOSA HAEMORRHAGICA 50 0.2155
6 BLOOD IMMUNOGLOBULIN M INCREASED 130 0.2138
7 CHRONIC LYMPHOCYTIC LEUKAEMIA 911 0.1918
8 CEREBRAL ASPERGILLOSIS 113 0.1837
9 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 122 0.1750
See all enriched reactions for IBRUTINIB